GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $172,000 | -0.6% | 3,955 | 0.0% | 0.03% | +16.7% |
| Q1 2022 | $173,000 | +143.7% | 3,955 | +147.2% | 0.02% | +84.6% |
| Q4 2021 | $71,000 | +16.4% | 1,600 | 0.0% | 0.01% | +18.2% |
| Q3 2021 | $61,000 | +7.0% | 1,600 | 0.0% | 0.01% | +10.0% |
| Q1 2021 | $57,000 | -3.4% | 1,600 | 0.0% | 0.01% | -9.1% |
| Q4 2020 | $59,000 | -16.9% | 1,600 | -15.8% | 0.01% | -21.4% |
| Q3 2020 | $71,000 | -9.0% | 1,900 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $78,000 | +2.6% | 1,900 | -5.0% | 0.02% | -11.1% |
| Q1 2020 | $76,000 | -5.0% | 2,000 | +17.6% | 0.02% | +20.0% |
| Q4 2019 | $80,000 | +370.6% | 1,700 | +325.0% | 0.02% | +400.0% |
| Q3 2019 | $17,000 | -41.4% | 400 | -44.6% | 0.00% | -50.0% |
| Q2 2019 | $29,000 | -3.3% | 722 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $30,000 | +25.0% | 722 | +16.1% | 0.01% | +20.0% |
| Q4 2018 | $24,000 | -4.0% | 622 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $25,000 | 0.0% | 622 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $25,000 | +31.6% | 622 | +38.2% | 0.01% | 0.0% |
| Q2 2017 | $19,000 | +5.6% | 450 | 0.0% | 0.01% | +66.7% |
| Q1 2017 | $18,000 | +50.0% | 450 | +50.0% | 0.00% | 0.0% |
| Q4 2016 | $12,000 | -7.7% | 300 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $13,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $13,000 | +8.3% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $12,000 | -50.0% | 300 | -50.0% | 0.00% | -50.0% |
| Q4 2015 | $24,000 | +4.3% | 600 | 0.0% | 0.01% | +14.3% |
| Q3 2015 | $23,000 | -8.0% | 600 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $25,000 | -73.7% | 600 | -71.0% | 0.01% | -70.8% |
| Q1 2015 | $95,000 | -99.9% | 2,067 | -27.9% | 0.02% | +20.0% |
| Q4 2014 | $65,525,000 | +78845.8% | 2,867 | +58.7% | 0.02% | -9.1% |
| Q3 2014 | $83,000 | -44.7% | 1,807 | -35.6% | 0.02% | -40.5% |
| Q2 2014 | $150,000 | +0.7% | 2,805 | 0.0% | 0.04% | -2.6% |
| Q1 2014 | $149,000 | 0.0% | 2,805 | 0.0% | 0.04% | -2.6% |
| Q4 2013 | $149,000 | +13.7% | 2,805 | +7.5% | 0.04% | +5.4% |
| Q3 2013 | $131,000 | +101.5% | 2,609 | +100.7% | 0.04% | +85.0% |
| Q2 2013 | $65,000 | – | 1,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |